NeoGenomics (NEO) Ratios

0 Followers

NeoGenomics Ratios

MX:NEO's free cash flow for Q2 2026 was $0.46. For the 2026 fiscal year, MX:NEO's free cash flow was decreased by $ and operating cash flow was $0.01. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	3.60	4.26	1.98	6.20	6.73
Quick Ratio	3.35	3.94	1.89	5.95	6.46
Cash Ratio	1.37	1.81	1.22	3.56	2.93
Solvency Ratio	0.02	-0.08	>-0.01	-0.02	-0.10
Operating Cash Flow Ratio	0.21	0.06	0.02	-0.02	-0.73
Short-Term Operating Cash Flow Coverage	4.06	1.10	0.03	0.00	0.00
Net Current Asset Value	$ -184.17M	$ -146.98M	$ -139.68M	$ -142.88M	$ -136.72M
Leverage Ratios
Debt-to-Assets Ratio	0.33	0.35	0.37	0.36	0.35
Debt-to-Equity Ratio	0.57	0.56	0.67	0.65	0.61
Debt-to-Capital Ratio	0.36	0.36	0.40	0.39	0.38
Long-Term Debt-to-Capital Ratio	0.32	0.33	0.27	0.36	0.35
Financial Leverage Ratio	1.72	1.63	1.82	1.79	1.74
Debt Service Coverage Ratio	1.94	-4.27	<0.01	-1.23	-8.87
Interest Coverage Ratio	-25.64	-17.61	-13.92	-15.60	-20.79
Debt to Market Cap	0.85	1.36	1.30	1.33	2.33
Interest Debt Per Share	17.39	18.58	24.16	24.64	24.90
Net Debt to EBITDA	23.50	-8.08	-157.72	-15.29	-4.22
Profitability Margins
Gross Profit Margin	42.92%	38.85%	43.92%	41.34%	36.86%
EBIT Margin	-6.86%	-14.64%	-11.21%	-15.24%	-29.77%
EBITDA Margin	1.68%	-5.32%	-0.23%	-2.98%	-16.15%
Operating Profit Margin	-8.63%	-9.09%	-13.94%	-18.21%	-30.92%
Pretax Profit Margin	-7.12%	-15.16%	-12.21%	-16.41%	-31.26%
Net Profit Margin	-6.77%	-14.85%	-11.92%	-14.87%	-28.30%
Continuous Operations Profit Margin	-6.77%	-14.85%	-11.92%	-14.87%	-28.30%
Net Income Per EBT	95.11%	97.97%	97.58%	90.60%	90.53%
EBT Per EBIT	82.44%	166.87%	87.59%	90.12%	101.09%
Return on Assets (ROA)	-3.84%	-7.94%	-4.81%	-5.23%	-8.29%
Return on Equity (ROE)	-6.31%	-12.91%	-8.72%	-9.34%	-14.45%
Return on Capital Employed (ROCE)	-5.31%	-5.20%	-6.89%	-6.80%	-9.55%
Return on Invested Capital (ROIC)	-5.03%	-5.07%	-5.83%	-6.14%	-8.61%
Return on Tangible Assets	-9.31%	-19.68%	-10.15%	-11.20%	-17.83%
Earnings Yield	-11.51%	-35.85%	-18.86%	-21.66%	-62.84%
Efficiency Ratios
Receivables Turnover	4.37	4.57	4.39	4.51	4.26
Payables Turnover	4.35	19.26	17.15	17.07	15.69
Inventory Turnover	16.12	15.57	13.85	14.37	13.26
Fixed Asset Turnover	4.61	4.45	3.80	3.22	2.57
Asset Turnover	0.57	0.53	0.40	0.35	0.29
Working Capital Turnover Ratio	2.71	2.50	1.66	1.16	0.92
Cash Conversion Cycle	22.36	84.41	88.25	85.00	89.99
Days of Sales Outstanding	83.55	79.91	83.18	80.98	85.72
Days of Inventory Outstanding	22.65	23.44	26.35	25.41	27.53
Days of Payables Outstanding	83.83	18.95	21.29	21.39	23.26
Operating Cycle	106.19	103.35	109.54	106.39	113.25
Cash Flow Ratios
Operating Cash Flow Per Share	0.85	0.20	0.28	-0.08	-2.66
Free Cash Flow Per Share	-0.28	-0.85	-1.34	-1.22	-3.90
CapEx Per Share	1.13	1.05	1.62	1.15	1.24
Free Cash Flow to Operating Cash Flow	-0.33	-4.16	-4.85	15.72	1.47
Dividend Paid and CapEx Coverage Ratio	0.75	0.19	0.17	-0.07	-2.14
Capital Expenditure Coverage Ratio	0.75	0.19	0.17	-0.07	-2.14
Operating Cash Flow Coverage Ratio	0.05	0.01	0.01	>-0.01	-0.11
Operating Cash Flow to Sales Ratio	0.03	<0.01	0.01	>-0.01	-0.13
Free Cash Flow Yield	-1.65%	-7.23%	-8.15%	-7.56%	-42.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-8.76	-2.80	-5.32	-4.62	-1.59
Price-to-Sales (P/S) Ratio	0.58	0.41	0.63	0.69	0.45
Price-to-Book (P/B) Ratio	0.57	0.36	0.46	0.43	0.23
Price-to-Free Cash Flow (P/FCF) Ratio	-60.72	-13.83	-12.26	-13.23	-2.37
Price-to-Operating Cash Flow Ratio	20.44	57.61	59.44	-207.95	-3.48
Price-to-Earnings Growth (PEG) Ratio	-0.16	-0.08	0.47	0.12	>-0.01
Price-to-Fair Value	0.57	0.36	0.46	0.43	0.23
Enterprise Value Multiple	58.16	-15.87	-434.01	-38.35	-7.01
Enterprise Value	749.41M	613.95M	655.79M	675.32M	577.30M
EV to EBITDA	58.16	-15.87	-434.01	-38.35	-7.01
EV to Sales	0.98	0.84	0.99	1.14	1.13
EV to Free Cash Flow	-101.89	-28.19	-19.27	-21.99	-5.96
EV to Operating Cash Flow	33.99	117.39	93.38	-345.78	-8.75
Tangible Book Value Per Share	-0.33	1.00	1.57	1.82	2.70
Shareholders’ Equity Per Share	30.31	32.65	35.62	37.51	40.17
Tax and Other Ratios
Effective Tax Rate	0.05	0.02	0.02	0.09	0.09
Revenue Per Share	29.56	28.39	26.08	23.57	20.52
Net Income Per Share	-2.00	-4.22	-3.11	-3.50	-5.81
Tax Burden	0.95	0.98	0.98	0.91	0.91
Interest Burden	1.04	1.04	1.09	1.08	1.05
Research & Development to Revenue	0.05	0.05	0.05	0.05	0.06
SG&A to Revenue	0.47	0.50	0.47	0.35	0.41
Stock-Based Compensation to Revenue	0.04	0.06	0.05	0.04	0.05
Income Quality	-0.43	-0.05	-0.09	0.02	0.46

Currency in USD